Table 3.
Category | Disease/Study Groups | Assoc 1 | Study Type | Location | Population | Sample Size | Age Group | Gender | Reference |
---|---|---|---|---|---|---|---|---|---|
Bone | Fractures | Yes | longitudinal | Gauteng | NA | 20, 20 | 6–29 y | M & F | [59] |
Bone | Rickets | Yes | cross-sectional | KwaZulu-Natal | Black African | 37 | 1–12 y | M & F | [60] |
Bone | Bone mineral density | Yes | cross-sectional | North-West | Black African | 658 | >45 y | F | [32] |
Bone | Growth stunting | Yes | cross-sectional | Northern Cape | NA | 150 | 2–5 y | M & F | [57] |
Bone | Rickets | No | cross-sectional | Gauteng | Black African | 114 | <2 y | M & F | [25] |
Bone | Metabolic bone disease | No | cross-sectional | Gauteng | Black African | 26 | 16–19 y | M | [61] |
Bone | Bone mineral density | No | cross-sectional | Gauteng | Black & Asian-Indian | 371, 343 | 18–65 y | M & F | [35] |
Bone | Under weight vs. normal weight | No | case-control | Limpopo | Black African | 145 | 3–5 y | M & F | [22] |
Bone/ID | BMD in HIV uninfected vs. HIV high CD4 vs. HIV low CD4 count | No | case-control | Gauteng | Black African | 98, 74, 75 | ≥18 y | F | [62] |
ID | Schistosomiasis (PZQ vs. PZQ + vitamin D vs. vitamin D vs. placebo) | Yes 2 | RCT | Mozambique border | NA | 14, 16, 14, 15 | 14–18 y | M | [63] |
ID | TB-Meningitis | Yes 3 | case-control | Western Cape | Black & Coloured | 42, 147 | 0–13 y | M & F | [64] |
ID | HIV replication (Summer vs. winter vs. winter + vitamin D) | Yes | longitudinal | Western Cape | Black African | 30 | 18–24 y | M & F | [38] |
ID | TB HIV (TB vs. HIV vs. TB-HIV vs. OD) | Yes | case-control | Western Cape | Black African | 93, 75, 99, 103 | ≥18 y | M & F | [65] |
ID | HIV-Cryptococcal Meningitis vs. HIV | No 4 | case-control | Western Cape | NA | 150, 150 | ≥21 y | M & F | [66] |
ID | HIV ART initiation | NA 5 | cross-sectional | Gauteng/KWN | NA | 270 | ≥18 y | M & F | [67] |
ID | HIV ART initiation | NA 5 | cross-sectional | Gauteng/KWN | NA | 270 | ≥18 y | M & F | [68] |
ID | Paradoxical TB-HIV IRIS vs TB-HIV no IRIS | No | case-control | KwaZulu-Natal | Black African | 11, 11 | 24–50 y | M & F | [69] |
ID | ART-associated TB vs HIV+TB- | No | case-control | KwaZulu-Natal | Black African | 18, 38 | 23–57 y | M & F | [69] |
NCD | Cardiovascular disease (blood pressure and pulse) | Yes | cross-sectional | North-West | Black African | 291 | >47 y | F | [34] |
NCD | Metabolic syndrome | No | cross-sectional | Gauteng | Black & Asian-Indian | 374, 350 | 18–65 y | M & F | [33] |
NCD | Obesity (total body fat, fat distribution) | No | cross-sectional | Gauteng | Black & Asian-Indian | 371, 343 | 18–65 y | M & F | [36] |
Nutrition | Alzheimer’s zinc deficiency (Zn vs. Zn ± vitamin A ± vitamin D) | Yes 6 | RCT | Western Cape | NA | 70/group | 55 y | M | [70] |
Nutrition | Alcohol use disorders vs. matched controls | Yes | cross-sectional | Western Cape | Mixed ancestry | 81, 81 | 12–16 y | M & F | [71] |
Assoc., association; ART, antiretroviral therapy; BMD, bone mineral density; C:C, case vs. control; CVD, cardiovascular disease; F, female; HIV, human immunodeficiency virus; ID, infectious disease; IRIS, immune reconstitution inflammatory disease; M, male; NA, not available; NCD, Non communicable disease; OD, other diseases; PZQ, praziquantel; RCT, randomised controlled trial; TB, tuberculosis. Bold indicates significant association. y, year; 1 Disease prevalence or disease-associated functional response negatively correlated with serum 25(OH)D levels or positively with vitamin D deficiency. 2 Vitamin D supplementation improved lymphocyte and eosinophil function in schistosomiasis-infected individuals, disease association not investigated. 3 Winter sunlight hours associated with TB-meningitis. 4 74% deficiency in HIV-meningitis patients, but no difference to HIV-only. 5 Multinational cohort (n = 30 of 270 from South Africa).HIV disease association not assessed (40%–50% deficient); initiation of Efavirenz containing ART regimes significantly decreased 25(OH)D levels. 6 Improved plasma zinc levels in combination Zn + vitamin A + vitamin D.